Overview

C-Reactive Protein Test (CRP) Market is expected to grow at a CAGR of 1.3% from the forecast period 2020-2027.

FutureWise Market Research has instantiated a report that report provides an intricate analysis of the Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the C-Reactive Protein Test (CRP) Market long with the growth opportunities present across this business vertical.

Major players included in the Market are:    

• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher
• Quest Diagnostics Incorporated
• Siemens
• Abbott Laboratories
• Laboratory Corporation of America Holdings
• Merck KGaA
• Abaxis, Inc.
• Ortho Clinical Diagnostics
• Getein Biotech, Inc.
• HORIBA, Ltd.
• Randox Laboratories Ltd.
• BODITECH MED, INC
• Aidian
• Eurolyser Diagnostica GmbH
• Abcam plc.
• Bio-Techne
• EKF Diagnostics
• SD Biosensor, Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

C-Reactive Protein Test (CRP) Market Segmentation:

By Assay Type

• ELISA
  o Clinical
  o Nonclinical
• Immunoturbidimetric
• CLIA
• Others

By Detection Range

• hs-CRP
• Conventional CRP
• cCRP

By Disease Area

• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

By End User

• Clinics
  o By Entity
    • Physician Offices
    • Small Clinics
    • Others
  o By Settings
    • Urban Setting
    • Rural Setting
• Hospitals
  o Urban Setting
  o Rural Setting
• Laboratories
  o Urban Setting
  o Rural Setting
• Assisted Living Healthcare Facilities
  o Urban Setting
  o Rural Setting
• Home
• Others

By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Market By Assay Type, By Detection Range, By Disease Area, By End User and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global C-Reactive Protein Test (CRP) Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global C-Reactive Protein Test (CRP) Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of C-Reactive Protein Test (CRP) Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global C-Reactive Protein Test (CRP) Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies
7. Global C-Reactive Protein Test (CRP) Market, By Assay Type Historical Analysis and Forecast 2020-2027 (USD Million)
        7.1. ELISA
              7.1.1. Clinical
              7.1.2. Nonclinical
        7.2. Immunoturbidimetric
        7.3. CLIA
        7.4. Others
8. Global C-Reactive Protein Test (CRP) Market, By Detection Range Historical Analysis and Forecast 2020-2027 (USD Million)
        8.1. hs-CRP
        8.2. Conventional CRP
        8.3. cCRP 
9. Global C-Reactive Protein Test (CRP) Market, By Disease Area Historical Analysis and Forecast 2020-2027 (USD Million)
        9.1. Cardiovascular Diseases
        9.2. Cancer
        9.3. Rheumatoid Arthritis 
        9.4. Inflammatory Bowel Disease
       9.5. Endometriosis
       9.6. Lupus
       9.7. Others
10. Global C-Reactive Protein Test (CRP) Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
    10.1. Clinics
          10.1.1. By Entity
                  10.1.1.1. Physician Offices
                  10.1.1.2. Small Clinics
                  10.1.1.3. Others
          10.1.2. By Settings
                  10.1.2.1. Urban Setting
                  10.1.2.2. Rural Setting
    10.2. Hospitals
          10.2.1. Urban Setting
          10.2.2. Rural Setting
    10.3. Laboratories
          10.3.1. Urban Setting
          10.3.2. Rural Setting
    10.4. Assisted Living Healthcare Facilities
          10.4.1. Urban Setting
          10.4.2. Rural Setting
    10.5. Home
    10.6. Others
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2020-2027 
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2020-2027  
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2020-2027           

16. Market Share Analysis and Competitive Landscape   
    16.1. Global Landscape - Key Players, Revenue and Presence
    16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    16.3. Global Emerging Companies
    16.4. North America - Market Share Analysis and Key Regional Players
    16.5. Europe - Market Share Analysis and Key Regional Players
    16.6. Asia Pacific - Market Share Analysis and Key Regional Players
    16.7. Global Key Player - Growth Matrix

17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    17.1. Thermo Fisher Scientific, Inc.
          17.1.1. Company Overview
          17.1.2. Product Portfolio
          17.1.3. SWOT Analysis
          17.1.4. Financial Overview
          17.1.5. Strategic Overview
    17.2. F. Hoffmann-La Roche Ltd.
          17.2.1. Company Overview
          17.2.2. Product Portfolio
          17.2.3. SWOT Analysis
          17.2.4. Financial Overview
          17.2.5. Strategic Overview 
    17.3. Danaher
          17.3.1. Company Overview
          17.3.2. Product Portfolio
          17.3.3. SWOT Analysis
          17.3.4. Financial Overview
          17.3.5. Strategic Overview
    17.4. Quest Diagnostics Incorporated
          17.4.1. Company Overview
          17.4.2. Product Portfolio
          17.4.3. SWOT Analysis
          17.4.4. Financial Overview
          17.4.5. Strategic Overview
    17.5. Siemens
          17.5.1. Company Overview
          17.5.2. Product Portfolio
          17.5.3. SWOT Analysis
          17.5.4. Financial Overview
          17.5.5. Strategic Overview          
    17.6. Abbott Laboratories
          17.6.1. Company Overview
          17.6.2. Product Portfolio
          17.6.3. SWOT Analysis
          17.6.4. Financial Overview
          17.6.5. Strategic Overview      
    17.7. Laboratory Corporation of America Holdings
          17.7.1. Company Overview
          17.7.2. Product Portfolio
          17.7.3. SWOT Analysis
          17.7.4. Financial Overview
          17.7.5. Strategic Overview
    17.8. Merck KGaA
          17.8.1. Company Overview
          17.8.2. Product Portfolio
          17.8.3. SWOT Analysis
          17.8.4. Financial Overview
          17.8.5. Strategic Overview 
    17.9. Abaxis, Inc.
          17.9.1. Company Overview
          17.9.2. Product Portfolio
          17.9.3. SWOT Analysis
          17.9.4. Financial Overview
          17.9.5. Strategic Overview 
    17.10.Ortho Clinical Diagnostics
          17.10.1. Company Overview
          17.10.2. Product Portfolio
          17.10.3. SWOT Analysis
          17.10.4. Financial Overview
          17.10.5. Strategic Overview
    17.11.Getein Biotech, Inc.
          17.11.1. Company Overview
          17.11.2. Product Portfolio
          17.11.3. SWOT Analysis
          17.11.4. Financial Overview
          17.11.5. Strategic Overview          
    17.12.HORIBA, Ltd.
          17.12.1. Company Overview
          17.12.2. Product Portfolio
          17.12.3. SWOT Analysis
          17.12.4. Financial Overview
          17.12.5. Strategic Overview      
    17.13.Randox Laboratories Ltd.
          17.13.1. Company Overview
          17.13.2. Product Portfolio
          17.13.3. SWOT Analysis
          17.13.4. Financial Overview
          17.13.5. Strategic Overview
    17.14.BODITECH MED, INC
          17.14.1. Company Overview
          17.14.2. Product Portfolio
          17.14.3. SWOT Analysis
          17.14.4. Financial Overview
          17.14.5. Strategic Overview 
    17.15.Aidian
          17.15.1. Company Overview
          17.15.2. Product Portfolio
          17.15.3. SWOT Analysis
          17.15.4. Financial Overview
          17.15.5. Strategic Overview 
    17.16.Eurolyser Diagnostica GmbH
          17.16.1. Company Overview
          17.16.2. Product Portfolio
          17.16.3. SWOT Analysis
          17.16.4. Financial Overview
          17.16.5. Strategic Overview
    17.17.Abcam plc.
          17.17.1. Company Overview
          17.17.2. Product Portfolio
          17.17.3. SWOT Analysis
          17.17.4. Financial Overview
          17.17.5. Strategic Overview
    17.18.Bio-Techne
          17.18.1. Company Overview
          17.18.2. Product Portfolio
          17.18.3. SWOT Analysis
          17.18.4. Financial Overview
          17.18.5. Strategic Overview
    17.19.EKF Diagnostics
          17.19.1. Company Overview
          17.19.2. Product Portfolio
          17.19.3. SWOT Analysis
          17.19.4. Financial Overview
          17.19.5. Strategic Overview
    17.20.SD Biosensor, INC.
          17.20.1. Company Overview
          17.20.2. Product Portfolio
          17.20.3. SWOT Analysis
          17.20.4. Financial Overview
          17.20.5. Strategic Overview

18. Pre and Post COVID-19 Impact
    18.1. Positive influence on the healthcare industry
    18.2. The financial disruption of the manufacturing sector
    18.3. Impact of COVID-19 on emerging companies
    18.4. Significant mandates in the healthcare regulations initiated by administrations
    18.5. The overall economic slowdown of the developing and developed nations

19. FutureWise SME Key Takeaway Points for Client
 

Tables

Figures